Breathtec BioMedical Inc.

(BTH:CNX)

By |
Breathtec BioMedical Inc.

Profile

Breathtec Biomedical, Inc. (“Breathtec”) was formed to propel innovative research in the area of breath analysis as a medical screening tool. Our efforts are aimed at leading the development of commercially viable methods for the early screening of diseases such as lung & breast cancers, neurodegenerative diseases (eg: Alzheimer’s / Parkinson’s), tuberculosis, diabetes, liver disease and more.

Issuer Information

Exchange: CNQ
CEO: Guy LaTorre
Issuer Type: CS - Common Stock
Sector/Industry: Cyclical
NAICS: In-Vitro Diagnos
$ 0.085 $ -0.005 (-5.56%)
Last Price 0.085 Change $ -0.005 Change % -5.56 Tick N/A
Bid 0.08 Bid Size 109,000.00 Ask 0.085 Ask Size 32,000.00
Open 0.085 High 0.085 Low 0.085 Prev Close 0.09
Last Trade Volume 98,500 52 Wk Hi 0.32 52 Wk Low 0.08
Market Cap 4.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 54,752,024.00 EPS (TTM) 0.04 PE Ratio 2.30 Exchange CSE